On the other hand, some MSI-L or even MSI-H (if two markers of the Bethesda panel are affected) tumors may in fact have only dinucleotide frameshifts, a defect which can be indicative of isolated MSH3 dysfunction, and thus share more similarities with EMAST than the MSI tumor phenotype [18]. This evidence concerns the gene MSH3 and neoplasm.